Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Ixekizumab (Anti-CTLA-8 / IL-17a) For research use only.
Not for use in humans.

Ixekizumab (Anti-CTLA-8 / IL-17a)

Synonyms: LY2439821

Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.

Ixekizumab (Anti-CTLA-8 / IL-17a)

Purity & Quality Control

Batch: A286201 Purity: 99% Protein concentration: 4.01mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Interleukins Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.

Product Details

CAS No. 1143503-69-8
Molecular Weight 146.44
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ixekizumab (Anti-CTLA-8 / IL-17a) | Ixekizumab (Anti-CTLA-8 / IL-17a) supplier | purchase Ixekizumab (Anti-CTLA-8 / IL-17a) | Ixekizumab (Anti-CTLA-8 / IL-17a) cost | Ixekizumab (Anti-CTLA-8 / IL-17a) manufacturer | order Ixekizumab (Anti-CTLA-8 / IL-17a) | Ixekizumab (Anti-CTLA-8 / IL-17a) distributor